Literature DB >> 7949408

An epidemiological study of attention-deficit hyperactivity disorder and major depression in a male prison population.

L L Eyestone1, R J Howell.   

Abstract

One hundred two inmates were interviewed and tested to determine epidemiological rates of attention-deficit hyperactivity disorder (ADHD) and depression in an adult male prison population. The Beck Depression Inventory, Hamilton Rating Scale, and four measures to assess childhood and adult ADHD were completed. The two disorders were diagnosed independently. Diagnosable ADHD was found to occur in 25.5 percent of the inmates, and major depression occurred in 25.5 percent of the inmates. A significant relationship between ADHD and depression was found to exist (p < .001). Having identified a major mental health problem in the prison population, implications include a need for further diagnosis and treatment of these disorders within a prison setting. The relationship between depression and ADHD also needs further examination.

Entities:  

Mesh:

Year:  1994        PMID: 7949408

Source DB:  PubMed          Journal:  Bull Am Acad Psychiatry Law        ISSN: 0091-634X


  10 in total

Review 1.  Prevalence of mental illnesses in US State prisons: a systematic review.

Authors:  Seth J Prins
Journal:  Psychiatr Serv       Date:  2014-07       Impact factor: 3.084

2.  Suicide risk and mental health co-morbidities in a probationer population.

Authors:  Roberto Cardarelli; Elizabeth Balyakina; Kendra Malone; Kimberly G Fulda; Michael Ellison; Ron Sivernell; Tanjina Shabu
Journal:  Community Ment Health J       Date:  2014-07-29

3.  Childhood attention deficit hyperactivity disorder, substance use, and adult functioning among incarcerated women.

Authors:  Kathleen A Hennessey; Michael D Stein; Cynthia Rosengard; Jennifer S Rose; Jennifer G Clarke
Journal:  J Atten Disord       Date:  2009-09-22       Impact factor: 3.256

4.  Attention deficit hyperactivity disorder symptoms, type of offending and recidivism in a prison population: The role of substance dependence.

Authors:  Jan C Román-Ithier; Rafael A González; María C Vélez-Pastrana; Gloria M González-Tejera; Carmen E Albizu-García
Journal:  Crim Behav Ment Health       Date:  2016-07-26

5.  Emotional processing modulates attentional capture of irrelevant sound input in adolescents.

Authors:  B Gulotta; G Sadia; E Sussman
Journal:  Int J Psychophysiol       Date:  2013-01-09       Impact factor: 2.997

6.  Substance Use Correlates of Depression among African American Male Inmates.

Authors:  Rhonda Conerly Holliday; Ronald L Braithwaite; Elleen Yancey; Tabia Akintobi; Danielle Stevens-Watkins; Selina Smith; C Lamonte Powell
Journal:  J Health Care Poor Underserved       Date:  2016

Review 7.  The identification and management of ADHD offenders within the criminal justice system: a consensus statement from the UK Adult ADHD Network and criminal justice agencies.

Authors:  Susan J Young; Marios Adamou; Blanca Bolea; Gisli Gudjonsson; Ulrich Müller; Mark Pitts; Johannes Thome; Philip Asherson
Journal:  BMC Psychiatry       Date:  2011-02-18       Impact factor: 3.630

Review 8.  Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths.

Authors:  David E Comings; Thomas J H Chen; Kenneth Blum; Julie F Mengucci; Seth H Blum; Brian Meshkin
Journal:  Theor Biol Med Model       Date:  2005-12-23       Impact factor: 2.432

9.  Co-morbid psychiatric disorders among incarcerated ADHD populations: a meta-analysis.

Authors:  S Young; O Sedgwick; M Fridman; G Gudjonsson; P Hodgkins; M Lantigua; R A González
Journal:  Psychol Med       Date:  2015-04-10       Impact factor: 7.723

10.  Decision-Making Deficits in ADHD Are Not Related to Risk Seeking But to Suboptimal Decision-Making: Meta-Analytical and Novel Experimental Evidence.

Authors:  Tycho J Dekkers; Joost A Agelink van Rentergem; Hilde M Huizenga; Hamutal Raber; Rachel Shoham; Arne Popma; Yehuda Pollak
Journal:  J Atten Disord       Date:  2018-12-06       Impact factor: 3.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.